首页 | 本学科首页   官方微博 | 高级检索  
     

降纤酶与其他药物治疗急性脑梗死对照研究的Meta分析
引用本文:蒋亚斌,朱宁. 降纤酶与其他药物治疗急性脑梗死对照研究的Meta分析[J]. 金属学报, 2002, 7(6): 496-499
作者姓名:蒋亚斌  朱宁
作者单位:暨南大学医学院第一附属医院急诊科,广州 510632
摘    要:目的 了解降纤酶与其他药物治疗急性脑梗死(ACI)疗效的差异。方法 应用Meta 分析对10 项研究降纤酶与其他药物治疗ACI 的效果进行同质性检验和合并效应量的估计。结果 ①同质性检验:χ2=6.8452,自由度为9,P >0.05 。②合并效应量的估计:OR合并=3.2353,OR合并95%可信区间为2.21 ~4.74 。OR合并的检验:χ2=36.2,P <0.001 。结论 降纤酶治疗ACI 的疗效显著优于目前常用药物,其在适应症、治疗剂量、给药方法及用药时限等方面与临床疗效的关系有待进一步研究。

关 键 词:急性脑梗死  降纤酶  Meta 分析  
收稿时间:2002-07-22
修稿时间:2002-08-03

Meta-analysis of the effectiveness of defrase and other drugs in treatment of acute cerebral infarction
JIANG Ya-Bin,ZHU Ning. Meta-analysis of the effectiveness of defrase and other drugs in treatment of acute cerebral infarction[J]. Acta Metallurgica Sinica, 2002, 7(6): 496-499
Authors:JIANG Ya-Bin  ZHU Ning
Affiliation:Department of Emergency,First Affiliated Hospital of JNUMC,Guangzhou 510632
Abstract:AIM: To explore the difference of efficacy between defibrase and other drugs in treatment of acute cerebral infarction.METHODS: The efficacies of defibrase or other drugs in treatment of acute cerebral infarction were analyzed by Meta-analysis in homogeneity test and combined test in 10 studies.RESULTS: (1)Homogeneity test showed that the cited studies were homogeneous with χ2=6.8452,p>0.05;and(2)in combined test,the combined OR=3.2353 and its 95% confidence interval was in 2.21 -4.74(χ2=36.2,p<0.001).CONCLUSION: The effectiveness of defibrase in treatment of acute cerebral infarction is significantly superior to those of the medications used at present.It is necessary to further investigate the relationships between its clinical efficacy and the dosages,and between protocols of drug administration and indications.
Keywords:acute cerebral infarction  defibrase  Meta-analysis  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号